Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor

PETAH TIKVA, Israel & BOCA RATON, Fla.--(BUSINESS WIRE)--Dec 30, 2025--

Biobeat Technologies, Ltd., developer of the first FDA-cleared, 24-hour ambulatory blood pressure monitoring (ABPM) system that is a patch-worn, cuff-less solution for diagnosis and treatment of hypertension, announced today the closing of a $50 million Series B equity financing.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251230446026/en/

The financing was led by new investors Ally Bridge Group, OrbiMed Advisors and Elevage Medical and included participation from a strategic investor. Proceeds from the financing will be used to expand commercialization in the United States.

Cuff-based ABPM devices have historically been underutilized due to their frequent and disruptive inflation cycles resulting in low patient compliance and logistical device and data collection issues for clinical staff. By contrast, the Biobeat sensor allows the patient to go about their daily activities and sleep undisturbed. At the completion of the ambulatory test, the device is disposed of by the patient and a high-quality report is generated automatically and available in seconds in the institution’s electronic medical records.

"I am delighted to welcome world-class venture capital investors Ally Bridge, OrbiMed and Elevage to the Biobeat team. We believe that Biobeat will have a profoundly positive impact on clinical utilization of ABPM, similar to what was experienced with ambulatory ECG monitoring once a patch-worn device became available," said Raymond W. Cohen, Executive Chairman of Biobeat.

The company also welcomed Steven Plachtyna of Ally Bridge, Dina Chaya of OrbiMed and Evan Melrose of Elevage to its Board of Directors.

Arik Ben Ishay, CEO of Biobeat, said, "This is an exciting time for the company as we bring on a talented field sales team to expand commercialization of our novel ABPM system. Based on our winning, clinically validated embodiment, the time has finally arrived to make ABPM a true standard of care to help diagnosis and titrate anti-hypertensive medications for the over 100 million hypertensive patients in the U.S.”

About Biobeat

Biobeat is an innovative company with operations in Tel Aviv, Israel and Boca Raton, Florida. Biobeat is focused on revolutionizing the blood pressure monitoring landscape by expanding the use of ABPM for hypertensive patients and providing 24-hour blood pressure data that allows for patient comfort and uninterrupted sleep while capturing critical nighttime BP measurements seamlessly and accurately. For more information visit https://www.bio-beat.com

About Ally Bridge Group

Ally Bridge Group is a global healthcare investment management firm focused on high impact life science innovation. The firm was founded by Frank Yu in 2013. The firm manages assets from offices in New York City and Hong Kong. Since establishment, Ally Bridge has led or co-led over $6 billion of transactions in healthcare. We seek to address unmet clinical needs via our investments. To learn more, please visit https://ally-bridge.com

About OrbiMed

OrbiMed is a leading healthcare investment firm, with over $19 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed's team of over 130 professionals is based in New York City, London, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets. To learn more, please visit https://www.orbimed.com

About Elevage Medical Technologies

Elevage Medical Technologies is a platform established by Patient Square Capital and is dedicated to supporting medical technology companies that can meaningfully improve health outcomes and quality of life for patients. Elevage provides capital along with deep technical, regulatory, and operational expertise to companies ranging from advanced clinical development to commercial acceleration stage. Elevage supports rapidly growing, highly differentiated companies with paradigm shifting technologies and strives to help build industry leading medical technologies. To learn more about Elevage, please visit www.elevagemedical.com

Biobeat is the first FDA-cleared Cuff-less 24-hour ambulatory blood pressure monitoring (ABPM) system that is a patch-worn, cuff-less solution for diagnosis and treatment of hypertension.

BOSTON (AP) — New England Patriots star wide receiver Stefon Diggs is facing strangulation and other criminal charges in connection with a dispute with his former private chef, police said.

News of the charges emerged after a court hearing Tuesday in Dedham, Massachusetts. Diggs is charged with felony strangulation or suffocation and misdemeanor assault and battery.

Diggs’ lawyer, David Meier, said in an emailed statement that Diggs “categorically denies these allegations.”

Meier said the allegations never occurred, describing them as unsubstantiated and uncorroborated. A court arraignment is scheduled for Jan. 23.

“The timing and motivation for making the allegations is crystal clear: they are the direct result of an employee-employer financial dispute that was not resolved to the employee’s satisfaction,” Meier wrote.

In a statement, the Patriots said they were also standing by Diggs: “We support Stefon,” the team said.

A police narrative in a court filing about the case said a woman came to the Dedham Police Department on Dec. 16 to say that two weeks earlier, while working as a private chef for Diggs, he came into her bedroom and became angry during a discussion about money. The woman told police Diggs “smacked her across the face,” she tried to push him away and then he “tried to choke her using the crook of his elbow around her neck.”

“She said that he was behind her with his arm wrapped around her,” wrote Officer Kenneth J. Ellis. “She said that she did feel like she had trouble breathing and that she felt like she could have blacked out.” Diggs threw her on a bed and said “lies” when she told him she had not been paid, Ellis wrote.

The chef sought payment for a week in November when Diggs was having houseguests and she had to go home, Ellis wrote. The woman “left her position” and the home in Dedham but returned on Dec. 9 to retrieve her property. At that point, she told police, Diggs referred her to his assistant, who told the woman she had to sign a non-disclosure agreement before she would be paid. She did not sign it, police said.

The woman was reluctant to file charges until last week, Ellis wrote, when “she let me know that she had changed her mind from a few days ago” and wanted criminal charges.

Diggs, 32, established himself as one of the NFL’s best wide receivers during a run with Minnesota and Buffalo from 2018 to 2023, when he had six consecutive 1,000-yard receiving seasons and was selected to the Pro Bowl four times.

After a lackluster stint in Houston last year, Diggs ended up in New England, signing a three-year, $69 million deal in free agency that guaranteed him $26 million.

Diggs has proven a reliable target for second-year quarterback Drake Maye and is a big reason why the team has once again clinched the AFC East title as the team heads toward the playoffs.

Off the field, though, his tenure with the Patriots got off to a rocky start when a video surfaced on social media in May showing Diggs passing what appeared to be a bag of pink crystals to women on a boat.

It wasn’t clear what the substance was, and an NFL spokesperson said the league would not comment. Patriots coach Mike Vrabel said the team would handle that matter internally.

Grammy Award-winning rapper Cardi B has posted photos in recent months of the newborn son she has with Diggs.

AP reporter Mark Scolforo in Harrisburg, Pennsylvania, contributed.

FILE - New England Patriots wide receiver Stefon Diggs (8) leaves the field following an NFL football game against the Cincinnati Bengals, Sunday, Nov 23, 2025, in Cincinnati, Ohio. (AP Photo/Peter Joneleit, File)

New England Patriots wide receiver Stefon Diggs (8) runs against the Baltimore Ravens during the second half of an NFL football game, Sunday, Dec. 21, 2025, in Baltimore. (AP Photo/Nick Wass)